升阳益胃汤治疗反复咳嗽变异性哮喘的临床价值  

Clinical efficacy of the Shengyang Yiwei decoction on cough variant asthma

作　　者：陈境烨 张同泰 杨日丰 Chen Jingye

机构地区：[1]广州市番禺区中医院,广东广州511400 [2]广州市番禺区中心医院,广东广州511400

出　　处：《中医临床研究》2019年第22期85-87,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:研究升阳益胃汤治疗反复咳嗽变异性哮喘(Cough Variant Asthma,CVA)的临床价值。方法:纳入70例门诊反复CVA患者作为研究对象,采用随机数字表法将患者分为两组,每组35例。观察组行常规西医治疗,对照组在常规治疗后加用升阳益胃汤。比较两组治疗前后症状积分和临床效果,记录两组患者治疗前后肺功能水平。记录治疗后1年复发率。结果:治疗后观察组咳嗽咽痒、胸闷气急及食少便溏积分显著低于治疗前和对照组评分,差异均有统计学意义(P<0.05)。观察组治疗后显效率显著高于对照组,治疗后1年复发率显著低于对照组,差异均有统计学意义(P<0.05)。治疗后观察组最大呼气流量(速)(Peak Expiratory Flow,PEF)变异率、第一秒最大呼气量(Forced Expiratory Volume In Is,FEV1)及FEV1/用力肺活量(Forced Vital Capacity,FVC)显著高于治疗前和对照组,差异有统计学意义(P<0.05)。结论:升阳益胃汤治疗反复发作的CVA患者疗效显著,能显著改善临床症状,改善肺功能,降低复发率。Objective: To study the clinical efficacy of the Shengyang Yiwei decoction (升阳益胃汤) on cough variant asthma. Methods: 70 patients were divided into two groups, 35 cases in each group. The observation group received routine western medicine. The control group received the Shengyang Yiwei decoction more. Results: The scores of cough, itching, chest tightness, shortness of breath and dysentery after treatment in the observation group were significantly lower than those before treatment and the control group (P<0.05). The efficiency in the observation group was significantly higher than the control group, the recurrence rate in the observation group was significantly lower at 1 year after treatment (P<0.05). The PEF variation rate, FEV1% and FEV1%/FVC in the observation group were significantly higher than those in the control group and before treatment (P<0.05). Conclusion: The Shengyang Yiwei decoction is effective on recurrent CVA, can significantly improve clinical symptoms, lung function, and reduce recurrence rate.

关 键 词：升阳益胃汤 咳嗽变异性哮喘 价值 

分 类 号：R256.12[医药卫生—中医内科学]